Publication | Closed Access

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Surgical OncologyMedicineEortc 18991MelanomaImmunologyCancer TreatmentAdjuvant TherapyOncologyRadiation OncologyFinal Results